Teva Pharmaceutical Industries LtdTEVA:TLV

25,370
140.00 / 0.55%
695.07k
35.16%
0.7608
Close in ILAToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Aug 27 2015 15:24 BST.

Summary

On Thursday, Teva Pharmaceutical Industries Ltd (TEVA:TLV) closed at 25,370, 8.05 % below its 52-week high of 27,590, set on Jul 27, 2015.

52-week range
Today
18,270
Sep 10 2014
27,590
Jul 27 2015
Open25,410
Day high25,780
Day low25,340
Bid25,370
Offer25,410
Previous close25,230
Average volume440.02k
Shares outstanding960.35m
Free float960.35m
P/E (TTM)21.72
Market cap242.31bn ILS
EPS (TTM)11.62 ILS
Data delayed at least 20 minutes, as of Aug 27 2015 15:24 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Teva Pharmaceutical Industries Ltd-5.27 %-2.57 %+13.51 %+35.16 %+33.81 %
TASE TA-100 IDX-5.34 %-4.72 %+4.04 %+10.27 %+33.33 %
IL/HEALTH CARE-5.56 %-5.56 %+11.90 %+26.61 %+25.27 %
IL/PHARMACEUTICALS-5.56 %-5.56 %+11.90 %+26.61 %+25.27 %
Data delayed at least 20 minutes, as of Aug 27 2015 15:24 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.